UNIVERSITY PARK, Pa. — The Eberly College of Science mourns the loss of Wesley Hymer, professor of biochemistry, who died May 4 at the age of 89. Over his 35 years on the faculty at Penn State, he made important contributions to the understanding of pituitary hormones and was internationally recognized for his pioneering research of living cells in space.
“Wes was a dedicated researcher and educator who was always full of energy and enthusiasm,” said Ross Hardison, professor emeritus of biochemistry and molecular biology at Penn State. “He had a long and productive career conducting research on the biochemical and cellular mechanisms by which pituitary hormones regulate growth and differentiation in mammalian tissues. He was the first person I heard talking about muscle loss and other negative physiological impacts of space travel and weightlessness. He ran an early, innovative research program studying these issues, including experiments conducted on space shuttle flights.”
A native of Wisconsin, Hymer earned bachelor's, master's and doctoral degrees at the University of Wisconsin-Madison and then served as a postdoctoral fellow and staff fellow at the National Institutes of Health’s National Cancer Institute. Hymer joined the faculty at Penn State in 1965 and retired with emeritus status in 2000.
Hymer’s research largely focused on pituitary glands and two of the hormones they produce, prolactin and growth hormone. This included topics such as the synthesis, processing and secretion of mammalian pituitary hormones, isolation of bioactive hormone forms and pituitary-cell separation.
“When I came to Penn State in 1966 as a graduate student in the Department of Biology, Wes was a new assistant professor from the NIH,” said Andrea Mastro, professor emeritus of microbiology and cell biology at Penn State and one of Hymer’s first graduate students. “He was carrying out cell and tissue culture in his laboratory, and these were exciting new areas.”
In 1983, Hymer was the principal investigator on the first experiment conducted aboard the space shuttle in which live cells were processed by a separation technique called electrophoresis. Over the next 10 years, he led five more cell studies that were conducted in space, including two in the Cosmos biosatellite series, a joint Russian-U.S. effort, and one that resulted as a collaboration with Japanese researchers. Hymer's space experiments with living cells developed conclusive evidence that the hormone output and activity of pituitary-gland cells is adversely affected by the lack of gravity in space, which may contribute to the bone loss of astronauts in space.
“We carried out some interesting collaborations with scientists from the Soviet Union,” said Mastro, who Hymer invited to participate in his work with NASA several years after she returned to Penn State as a faculty member. “Our travel included several weeks in Moscow along with some other American scientists. This led to long-term collaborations and to some of the Russian scientists visiting our labs.”
In 1987, Hymer was awarded $5 million from the NASA Centers for the Commercial Development of Space program to launch the Center for Cell Research (CCR) at Penn State. For several years, the center focused on developing commercial biomedical and biotechnical experiments based on the idea that space could be used as a testbed for the development of new medicines. This resulted in experiments with Genentech, Merck, Bristol-Meyers Squibb, Merocel Corp., Boehringer Ingelheim, Clontech Laboratories, the Space Dermatology Foundation, and Genetics Institute.
By 1993, when NASA changed its focus and retired the Centers for the Commercial Development of Space program, the CCR had flown commercial experiments aboard four space shuttle missions and three sounding-rocket flights, developed four patented products, and renewed NASA's interest in electrophoresis as a space-processing technique.